Literature DB >> 23343338

Usefulness of steroid administration for diagnosis of IgG4-related sclerosing cholangitis.

Norio Kubo1, Hideki Suzuki, Tsutomu Kobayashi, Kenichiro Araki, Shigeru Sasaki, Wataru Wada, Hiroyuki Kuwano.   

Abstract

Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) is one of the IgG4-related systemic sclerosing diseases and responds well to steroid therapy. A 58-year-old male was admitted with hilar bile duct stenosis revealed by computed tomography. We performed percutaneous transhepatic right portal vein embolization (PTPE) and scheduled a right hepatectomy because a hilar cholangiocarcinoma was first suspected. However, there was no cytologic evidence of malignancy and serum IgG4 was elevated. Steroid therapy was initiated after PTPE. There was no evidence of bile duct stenosis after 4 weeks. Improving diagnostic technique, IgG4-SC was diagnosed and treated with steroid therapy. In some cases, we couldn't deny the malignancy and performed unnecessary resection. We recommend that steroid administration while waiting for the liver volume to increase after PTPE is useful. The therapy aids in the diagnosis of bile duct stenosis, which has value for a hilar bile duct limit type of IgG4-SC, as in the case reported here.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23343338      PMCID: PMC3723206          DOI: 10.9738/CC78.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  19 in total

1.  Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures.

Authors:  D Erdogan; J J Kloek; F J W ten Kate; E A J Rauws; O R C Busch; D J Gouma; T M van Gulik
Journal:  Br J Surg       Date:  2008-06       Impact factor: 6.939

2.  Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells.

Authors:  Masanori Koyabu; Kazushige Uchida; Norimasa Fukata; Takeo Kusuda; Tsukasa Ikeura; Yutaku Sakaguchi; Katsunori Yoshida; Masaaki Shimatani; Toshiro Fukui; Mitsunobu Matsushita; Yoshiko Uemura; Masaki Kaibori; Makoto Takaoka; Akiyoshi Nishio; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2009-09-18       Impact factor: 7.527

3.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

4.  Endoscopic transpapillary bile duct biopsy with the combination of intraductal ultrasonography in the diagnosis of biliary strictures.

Authors:  K Tamada; T Tomiyama; S Wada; A Ohashi; Y Satoh; K Ido; K Sugano
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

5.  Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.

Authors:  Suresh T Chari; Thomas C Smyrk; Michael J Levy; Mark D Topazian; Naoki Takahashi; Lizhi Zhang; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Michael B Farnell
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-14       Impact factor: 11.382

6.  Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.

Authors:  Masanori Koyabu; Kazushige Uchida; Hideaki Miyoshi; Yutaku Sakaguchi; Toshiro Fukui; Hiroki Ikeda; Makoto Takaoka; Junko Hirohara; Akiyoshi Nishio; Yoshiko Uemura; Shinji Uemoto; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2010-01-20       Impact factor: 7.527

7.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

8.  Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis.

Authors:  Hyoung-Chul Oh; Jae Gyu Kim; Jeong Wook Kim; Kwang Sun Lee; Mi Kyung Kim; Kyong Choun Chi; Yong Seok Kim; Ki Hyun Kim
Journal:  Intern Med       Date:  2008-12-01       Impact factor: 1.271

Review 9.  IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

10.  Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

Authors:  Amaar Ghazale; Suresh T Chari; Lizhi Zhang; Thomas C Smyrk; Naoki Takahashi; Michael J Levy; Mark D Topazian; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Keith Lindor; Michael B Farnell
Journal:  Gastroenterology       Date:  2007-12-07       Impact factor: 22.682

View more
  1 in total

1.  Immunoglobulin G4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case.

Authors:  Atsushi Miki; Yasunaru Sakuma; Hideyuki Ohzawa; Yukihiro Sanada; Hideki Sasanuma; Alan T Lefor; Naohiro Sata; Yoshikazu Yasuda
Journal:  Int Surg       Date:  2015-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.